Results 21 to 30 of about 4,497,204 (150)

The problem of timely diagnosis of primary hyperaldosteronism. Clinical case

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2023
A clinical case is presented of delayed diagnosis of primary hyperaldosteronism (PHA) due to aldosterone-producing adenoma. Suspicion of PHA arises in case of persistent combination of hypertension with hypokalemia of various severity, a specific ...
V.M. Zhdan   +6 more
doaj   +1 more source

Spectrum of Clinical and Pathogenetic Forms of Primary Hyperaldosteronism

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2015
The aim of the study was to investigate the spectrum of different pathogenetic forms of primary hyperaldosteronism on the clinical data of Ukrainian Scientific and Practical Center of Endocrine Surgery, Endocrine Organs and Tissues Transplantation within
L.V. Shchekaturova
doaj   +1 more source

Primary hyperaldosteronism presenting as hypokalaemic periodic paralysis

open access: yesSri Lanka Journal of Diabetes Endocrinology and Metabolism, 2019
Hypokalaemic periodic paralysis is episodic painless muscle weakness associated with areflexia (1). Hypertension and hypokalaema are the classic presentation of primary hyperaldoteronism though some patients can be normokalaemic (2).
A. S. Embuldeniya   +3 more
doaj   +1 more source

Renin dependent hypertension caused by accessory renal arteries

open access: yesClinical Hypertension, 2018
Background Hypokalemia in the presence of hypertension is often attributed to primary hyperaldosteronism as a cause of secondary hypertension, however secondary hyperaldosteronism may present similarly.
Pei Lin Chan, Florence Hui Sieng Tan
doaj   +1 more source

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy

open access: yesРациональная фармакотерапия в кардиологии, 2023
The literature review is devoted to modern ideas about the role of hyperaldosteronism as one of the important pathophysiological links in hypertension (HTN) development.
S. R. Gilyarevsky, D. O. Ladygina
doaj   +1 more source

Diagnosis and Treatment of Conn Syndrome: A Case Study

open access: yesJurnal Penyakit Dalam Indonesia, 2017
Acute neuromuscular disorder is a commonly found medical condition, which may prove to be fatal in certain conditions. Hypokalemia is one possible cause of neuromuscular disorder.
Muhammad Syah Abdaly   +2 more
doaj   +1 more source

Secondary hyperaldosteronism leading to resistant hypertension in a patient with adrenal Cushing’s syndrome

open access: yesSri Lanka Journal of Diabetes Endocrinology and Metabolism, 2020
Background Cushing’s syndrome (CS) is a rare disorder caused by prolonged hypercortisolism leading to increased morbidity and mortality. Hypertension in Cushing’s syndrome could be caused by multiple mechanism including primary hyperaldosteronism from co-
I. Ranathunga, N. P. Somasundaram
doaj   +1 more source

Rhabdomyolysis as first presentation of the Conn’s syndrome: a clinical case

open access: yesArterial Hypertension
Primary hyperaldosteronism is the leading cause of secondary hypertension, often presented with hypokalemia and even rare with its consequences. We describe a case of a 62-year-old man admitted to the emergency department with rhabdomyolysis from severe ...
Irida Kecaj   +7 more
doaj   +1 more source

Primary hyperaldosteronism: challenges in subtype classification

open access: yesBMC Research Notes, 2012
Background Primary hyperaldosteronism (PA) is a serious and potentially debilitating disease. Detailed guidelines have been written to guide endocrinologists in establishing the diagnosis of PA as well as in subtype classification of PA. The objective of
Layden Brian T   +2 more
doaj   +1 more source

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy